FDBusiness.com

GlaxoSmithKline to Sell Lucozade and Ribena Brands

 Breaking News
  • 2 Sisters Food Group Sells Christmas Puddings Business to Valeo Foods 2 Sisters Food Group is selling its Matthew Walker Christmas puddings business to Valeo Foods Group, the fast-growing international ambient foods producer, for £67 million. The Matthew Walker business, based...
  • Carlsberg Gives Latest Green Fibre Bottle Update Carlsberg Group has given an update on its journey to create the world’s first ‘paper’ beer bottle made from sustainably-sourced wood fibres that is both 100% bio-based and fully recyclable....
  • Loma Launches New RUN-WET IQ4 Metal Detector Loma Systems, a leading manufacturer of high performance metal detectors, checkweighers and x-ray inspection systems for the global food and pharmaceutical industries, has introduced new RUN-WET® specification to its range...
  • Campari Group Expands Brands Portfolio Campari Group, the Italian and international drinks business, has acquired a controlling interest in Mexican super premium brands Ancho Reyes spicy liqueur and Montelobos mezcal. In 2018 the net sales...
  • Winners of the 2019 Global Bottled Water Awards The winners of the 2019 Global Bottled Water Awards were announced at an awards ceremony held at the iconic Burj Al Arab, during the 16th Global Bottled Water Congress in...

GlaxoSmithKline to Sell Lucozade and Ribena Brands

GlaxoSmithKline to Sell Lucozade and Ribena Brands
April 26
15:44 2013

UK-based global pharmaceutical and healthcare group GlaxoSmithKline has decided to dispose of its Lucozade glucose energy and sports drinks, and Ribena fruit juice-based drinks brands. The two brands are part of GSK’s Nutrition business which is incorporated within the group’s Consumer Healthcare division. The disposal is part of GSK’s efforts to reshape its business, improve strategic focus and enhance its growth profile.

“In April 2013, we completed the strategic review of our nutritional drinks brands Lucozade and Ribena and concluded that the tremendous growth potential of these iconic brands, particularly outside the ‘core’ Western markets, could be better leveraged by companies with existing category presence and infrastructure in these regions,” explains Sir Andrew Witty, chief executive of GlaxoSmithKline. “As a result, we have decided to pursue the divestment of these brands, subject to the realisation of appropriate value for GSK shareholders.”

GSK’s Nutrition sales grew 6% to £280 million in the first quarter. The category performance was driven by strong growth of the Horlicks brand inIndia(up 16%) and the Boost energy drink (up 23%). Ribena sales grew 2% but Lucozade was down 2%.


Warning: count(): Parameter must be an array or an object that implements Countable in /home/fdbusiness/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share

About Author

mike

mike

Related Articles

Food & Drink Business Conference & Exhibition 2016

Upcoming Events

[eventlist]

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements